Similar Papers

Paper Title
Journal
Date
Author
SWITCHING TO RIOCIGUAT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION NOT AT TREATMENT GOAL WITH PHOSPHODIESTERASE TYPE-5 INHIBITORS: SUBGROUP ANALYSIS RESULTS OF THE REPLACE STUDY
...
Chest | VOL. 158
, et. al. ...
01 Oct 2020
Pharmacological management of pulmonary arterial hypertension.
Beatrice Adams ... Kevin T Ferguson
AACN advanced critical care | VOL. 25
Beatrice Adams, et. al.Beatrice Adams ... Kevin T Ferguson
01 Jan 2014
Idiopathic Pulmonary Arterial Hypertension in Asians
Genevieve M.Y Tan ... James W.L Yip
Chest | VOL. 147
Genevieve M.Y Tan, et. al.Genevieve M.Y Tan ... James W.L Yip
01 Apr 2015
Multicentre study on pulmonary arterial hypertension therapies in fontan patients: underutilised or of limited use?
A Constantine ... P Jenkins
European Heart Journal | VOL. 41
A Constantine, et. al.A Constantine ... P Jenkins
01 Nov 2020
View more papers

More From: British Journal of Clinical Pharmacology

Paper Title
Journal
Date
Author
Carbapenems in the management of valproic acid overdose (MPT-01166-24 R1).
David N Juurlink
British journal of clinical pharmacology | VOL. -
David N JuurlinkDavid N Juurlink
15 Jan 2025
The efficacy of hydroxychloroquine in paediatric chronic immune thrombocytopenia: A retrospective cohort study.
Jing Liu ... Juan Xiao
British journal of clinical pharmacology | VOL. -
Jing Liu, et. al.Jing Liu ... Juan Xiao
15 Jan 2025
Performance of the accelerated assessment of the European Medicines Agency.
Vittorio Del Grosso ... Armando A Genazzani
British journal of clinical pharmacology | VOL. -
Vittorio Del Grosso, et. al.Vittorio Del Grosso ... Armando A Genazzani
10 Jan 2025
Common pitfalls in oncology drug applications aiming for conditional marketing authorization.
Sinan B Sarac ... Amy Mckee
British journal of clinical pharmacology | VOL. -
Sinan B Sarac, et. al.Sinan B Sarac ... Amy Mckee
10 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.